Literature DB >> 25621310

Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Xuesong Chen, Liang Hui, Mahmoud L Soliman, Jonathan D Geiger.   

Abstract

Compared to the rare familial early onset Alzheimer's disease (AD) that results from gene mutations in AbPP and presenilin-1, the pathogenesis of sporadic AD is much more complex and is believed to result from complex interactions between nutritional, environmental, epigenetic and genetic factors. Among those factors, the presence APOE4 is still the single strongest genetic risk factor for sporadic AD. However, the exact underlying mechanism whereby apoE4 contributes to the pathogenesis of sporadic AD remains unclear. Here, we discuss how altered cholesterol intracellular trafficking as a result of apoE4 might contribute to the development of pathological hallmarks of AD including brain deposition of amyloid beta (Ab), neurofibrillary tangles, and synaptic dysfunction.

Entities:  

Keywords:  Alzheimer’s disease; ApoE4; Cholesterol; Niemann-Pick type C disease

Year:  2014        PMID: 25621310      PMCID: PMC4302957          DOI: 10.13188/2376-922x.1000002

Source DB:  PubMed          Journal:  J Parkinsons Dis Alzheimers Dis        ISSN: 2376-922X


  123 in total

1.  Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.

Authors:  A Kenessey; P Nacharaju; L W Ko; S H Yen
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

Review 2.  Lipid imbalance in the neurological disorder, Niemann-Pick C disease.

Authors:  Jean E Vance
Journal:  FEBS Lett       Date:  2006-06-15       Impact factor: 4.124

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice.

Authors:  N Sawamura; J S Gong; W S Garver; R A Heidenreich; H Ninomiya; K Ohno; K Yanagisawa; M Michikawa
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

Review 5.  Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime.

Authors:  MaryKate McBrayer; Ralph A Nixon
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

6.  Self-association and stability of the ApoE isoforms at low pH: implications for ApoE-lipid interactions.

Authors:  Kanchan Garai; Berevan Baban; Carl Frieden
Journal:  Biochemistry       Date:  2011-06-29       Impact factor: 3.162

7.  Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

8.  Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.

Authors:  Limor Avrahami; Dorit Farfara; Maya Shaham-Kol; Robert Vassar; Dan Frenkel; Hagit Eldar-Finkelman
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

Review 9.  Central nervous system: cholesterol turnover, brain development and neurodegeneration.

Authors:  John M Dietschy
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  3 in total

1.  Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model.

Authors:  Do-Geun Kim; Antje Krenz; Leon E Toussaint; Kirk J Maurer; Sudie-Ann Robinson; Angela Yan; Luisa Torres; Margaret S Bynoe
Journal:  J Neuroinflammation       Date:  2016-01-05       Impact factor: 8.322

Review 2.  Astrocytic Propagation of Tau in the Context of Alzheimer's Disease.

Authors:  Rebecca M Fleeman; Elizabeth A Proctor
Journal:  Front Cell Neurosci       Date:  2021-03-17       Impact factor: 5.505

Review 3.  Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.

Authors:  Sage C Arbor; Mike LaFontaine; Medhane Cumbay
Journal:  Yale J Biol Med       Date:  2016-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.